Showing 17 of 17 recruiting trials for “OBSOLETE: Inherited retinal disorder”
A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
A Study of LX107 Gene Therapy in AIPL1-IRD Patients
🏥 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jul 2025View details ↗
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
🏥 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Apr 2025View details ↗
Enrolling by InvitationNCT07056738 ↗
Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients
👨⚕️ Emilie Macé, Professor, Else Kroener Fresenius Center for Optogenetic Therapies, University Medical Center Goettingen📍 1 site📅 Started Mar 2025View details ↗
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients
RecruitingNCT06323772 ↗
Natural History Study in Patients with PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
👨⚕️ Janssen Pharmaceutical K.K., Japan Clinical Trial, Janssen Pharmaceutical K.K.📍 1 site📅 Started Sep 2023View details ↗
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene
👨⚕️ Katarina Stingl, Center for Ophthalmology, University of Tuebingen📍 1 site📅 Started Sep 2023View details ↗
Enrolling by InvitationNCT05921162 ↗
A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
Promising ROd-cone DYstrophy Gene therapY
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
👨⚕️ Chadwick Prodromos, MD, The Foundation for Orthopaedics and Regenerative Medicine📍 2 sites📅 Started Feb 2022View details ↗
RecruitingNCT04658251 ↗
Study of New Mutations in Cone Disorders
RecruitingNCT02471287 ↗
Genetics of Inherited Eye Disease
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →